Promotions & Moves

CorMedix Appoints CFO

Matt David, M.D. has more than 15 years of experience in finance as a healthcare investment banker and earlier as an equity analyst covering the pharma sector

By: Contract Pharma

Contract Pharma Staff

CorMedix Inc., a biopharmaceutical company focused on therapeutics for the prevention and treatment of infectious and inflammatory disease, has appointed Matt David, M.D. as Executive Vice President and Chief Financial Officer. Dr. David was most recently Head of Strategy at Ovid Therapeutics, a Nasdaq-listed biopharmaceutical company focused on rare neurological diseases. In addition to his recent experience in industry, Dr. David has more than 15 years of experience in finance as a healthca...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters